BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38357836)

  • 1. Hepatitis C virus infection in patients undergoing surgery in a single tertiary academic center.
    Lee JS; Lee HW; Kim MN; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1155-1163. PubMed ID: 38357836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea.
    Lee JS; Choi HJ; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2479-2485. PubMed ID: 33788314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change in hepatitis C virus positivity among needle-stick injury source patients: a 10-year experience in a Japanese tertiary hospital.
    Okushin K; Suzuki R; Tsutsumi T; Okamoto K; Ikeuchi K; Kado A; Minatsuki C; Minami-Kobayashi Y; Satoh N; Ikeda M; Harada S; Enooku K; Fujinaga H; Yotsuyanagi H; Koike K; Moriya K
    BMC Infect Dis; 2021 Apr; 21(1):399. PubMed ID: 33931015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital.
    İskender G; Mert D; Çeken S; Bahçecitapar M; Yenigün A; Ertek M
    J Infect Dev Ctries; 2020 Jun; 14(6):642-646. PubMed ID: 32683355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a Hepatitis C screening program at a large urban VA medical center.
    Groom H; Dieperink E; Nelson DB; Garrard J; Johnson JR; Ewing SL; Stockley H; Durfee J; Jonk Y; Willenbring ML; Ho SB
    J Clin Gastroenterol; 2008 Jan; 42(1):97-106. PubMed ID: 18097298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.
    Adland E; Jesuthasan G; Downs L; Wharton V; Wilde G; McNaughton AL; Collier J; Barnes E; Klenerman P; Andersson M; Jeffery K; Matthews PC
    BMC Infect Dis; 2018 Sep; 18(1):461. PubMed ID: 30217169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.
    Shaikh OS; Rogal S; Malik A; Sharma V; Cacciarelli T
    Exp Clin Transplant; 2020 Oct; 18(5):605-611. PubMed ID: 31324136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The care cascade for hepatitis C virus and prognosis of chronic hepatitis C patients treated with antiviral agents in a tertiary hospital.
    Yoo SH; Kim M; Kim S; Lee JI; Lee KS; Lee HW; Lim JH
    BMC Gastroenterol; 2023 Apr; 23(1):116. PubMed ID: 37041473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
    Torres HA; Lok AS; Suarez-Almazor ME; Warneke CL; Kaseb A; Miller E; Sturgis EM; Foreman JT; Angelidakis G; Ahmed S; Ferrajoli A; Samaniego F; Hawk ET; Hwang JP
    Support Care Cancer; 2021 Jan; 29(1):97-105. PubMed ID: 32314052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
    Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
    World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
    Kileng H; Gutteberg T; Goll R; Paulssen EJ
    BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.
    Carvalho-Louro DM; Soares EB; Trevizoli JE; Marra TMG; da Cunha ALR; Rodrigues MP; Carvalho-Furtado ACL; Dos Santos BTA; de Assis da Rocha Neves F
    BMC Infect Dis; 2020 Feb; 20(1):114. PubMed ID: 32041537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis C infection on renal transplant patients: a single-center experience in Libya.
    Elzouki AN; Gargoum HM; Habas EM; Rayani AA; Othman M
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1315-20. PubMed ID: 25394459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.
    Papadopoulos N; Manolakopoulos S; Deutsch M; Mela M; Christidou A; Katoglou A; Tzourmakliotis D; Papatheodoridis GV
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):587-93. PubMed ID: 23426269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of liver biopsy in anti-hepatitis C virus antibody-positive and hepatitis C virus RNA-negative kidney transplant recipients.
    Kim SM; Kim HW; Lee EK; Park SK; Han DJ; Kim SB
    Transplantation; 2013 Jul; 96(1):85-90. PubMed ID: 23632392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.